Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.4160
H.R.4160: Orphan Drug Act Amendments of 1994
About This Bill
- This bill was introduced in the 103rd Congress
- This bill is primarily about government operations and politics
- Introduced March 24, 1994
- Latest Major Action Aug. 5, 1994
Bill Sponsor
Bill Cosponsor
Bill Summary
Orphan Drug Act Amendments of 1994 - Amends the Federal Food, Drug, and Cosmetic Act to change from seven to four years the period of market exclusivity guaranteed to any approved orphan drug. Specifies that orphan drugs of "limited commercial potential," as defined by regulations to be issued by the Department of Health and Human Services, would qualify for an additional three years of exclusive marketing rights. Permits more than one company...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Sponsor introductory remarks on measure.
|
|
|
Referred to the House Committee on Energy and Commerce.
|
|
|
Referred to the Subcommittee on Health and the Environment.
|
|
|
Subcommittee Hearings Held.
|
|
|
Subcommittee Consideration and Mark-up Session Held.
|
|
|
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 15 - 10.
|
|
|
For Further Action See H.R.4865.
|
|
| March 24, 1994 |
Introduced in the House by Henry A. Waxman (D-Calif.) |